Last reviewed · How we verify

Procalamine — Competitive Intelligence Brief

Procalamine (PHOSPHORIC ACID) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Non-Standardized Fungal Allergenic Extract [EPC]. Area: Bone.

marketed Non-Standardized Fungal Allergenic Extract [EPC] Bone Small molecule Live · refreshed every 30 min

Target snapshot

Procalamine (PHOSPHORIC ACID) — B Braun.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Procalamine TARGET PHOSPHORIC ACID B Braun marketed Non-Standardized Fungal Allergenic Extract [EPC] 1971-01-01
Hair-X Hair Loss Relief SELENIUM Chattem marketed Non-Standardized Fungal Allergenic Extract [EPC] 1997-01-01
Shame SEROTONIN Deseret Biologicals, Inc. marketed Non-Standardized Fungal Allergenic Extract [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Non-Standardized Fungal Allergenic Extract [EPC] class)

  1. B Braun · 1 drug in this class
  2. Chattem · 1 drug in this class
  3. Deseret Biologicals, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Procalamine — Competitive Intelligence Brief. https://druglandscape.com/ci/phosphoric-acid. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: